@article{oai:kanazawa-u.repo.nii.ac.jp:00013641,
 author = {Ohata, Kinya and Iwaki, Noriko and Kotani, Takeharu and Kondo, Yukio and Yamazaki, Hirohito and Nakao, Shinji},
 issue = {2},
 journal = {Acta Haematologica},
 month = {Dec},
 note = {Lymphoproliferative disorders (LPDs) are generally caused by uncontrolled B-cell proliferation induced by the Epstein-Barr virus (EBV) in the setting of impaired EBV-specific T-cell immunity, particularly when there is pharmacological immunosuppression including antithymocyte globulin. We herein present an unusual case of EBV associated with LPD (EBV-LPD) in which LPD occurred 3 weeks after the use of rabbit antithymocyte globulin administered for severe hepatitis-associated aplastic anemia; the patient died of fulminant leukemic lymphoma 5 days after the onset. We also review the pertinent literature on EBV-LPD after immunosuppressive therapy and document the efficacy of EBV viral load monitoring and the need for preemptive therapy. Copyright © 2011 S. Karger AG, Basel.},
 pages = {96--99},
 title = {An Epstein-Barr Virus-Associated Leukemic Lymphoma in a Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine for Hepatitis-Associated Aplastic Anemia},
 volume = {127},
 year = {2011}
}